"Galectin 3" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A multifunctional galactin initially discovered as a macrophage antigen that binds to IMMUNOGLOBULIN E, and as 29-35-kDa lectin that binds LAMININ. It is involved in a variety of biological events including interactions with galactose-containing glycoconjugates, cell proliferation, CELL DIFFERENTIATION, and APOPTOSIS.
Concept/Terms
Galectin 3- Galectin 3
- CBP-30
- CBP-35
- CBP35
- Epsilon-Binding Protein
- Epsilon Binding Protein
- Galectin-3
- HL-29
- IgE Binding Protein
- Binding Protein, IgE
- Protein, IgE Binding
- IgEBP
- L-29 Lectin
- L 29 Lectin
- L-31
- L-34
- L30 Lectin
- LGALS3
- Mac-2 Antigen
- Antigen, Mac-2
- Mac 2 Antigen
- Macrophage-2 Antigen
- Antigen, Macrophage-2
- Macrophage 2 Antigen
- Carbohydrate-Binding Protein 35
- Carbohydrate Binding Protein 35
Below are MeSH descriptors whose meaning is more general than "Galectin 3".
Below are MeSH descriptors whose meaning is more specific than "Galectin 3".
This graph shows the total number of publications written about "Galectin 3" by people in Harvard Catalyst Profiles by year, and whether "Galectin 3" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 2003 | 0 | 2 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 2 | 3 |
| 2006 | 1 | 0 | 1 |
| 2007 | 1 | 0 | 1 |
| 2008 | 3 | 0 | 3 |
| 2009 | 5 | 2 | 7 |
| 2010 | 3 | 1 | 4 |
| 2011 | 2 | 2 | 4 |
| 2012 | 3 | 2 | 5 |
| 2013 | 5 | 0 | 5 |
| 2014 | 8 | 1 | 9 |
| 2015 | 11 | 3 | 14 |
| 2016 | 7 | 6 | 13 |
| 2017 | 2 | 2 | 4 |
| 2018 | 8 | 2 | 10 |
| 2019 | 3 | 3 | 6 |
| 2020 | 3 | 1 | 4 |
| 2021 | 3 | 2 | 5 |
| 2022 | 4 | 5 | 9 |
| 2023 | 1 | 4 | 5 |
| 2024 | 3 | 1 | 4 |
Below are the most recent publications written about "Galectin 3" by people in Profiles.
-
Galectin-3 in chronic kidney disease. Clin Chim Acta. 2024 Jun 01; 559:119727.
-
Galectin-3 does not interact with RNA directly. Glycobiology. 2024 Mar 19; 34(1).
-
Targeting Galectin 3 illuminates its contributions to the pathology of uterine serous carcinoma. Br J Cancer. 2024 May; 130(9):1463-1476.
-
MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure. ESC Heart Fail. 2024 Jun; 11(3):1400-1410.
-
Insights into the Role of Galectin-3 as a Diagnostic and Prognostic Biomarker of Atrial Fibrillation. Dis Markers. 2023; 2023:2097012.
-
APOE4 impairs the microglial response in Alzheimer's disease by inducing TGFß-mediated checkpoints. Nat Immunol. 2023 Nov; 24(11):1839-1853.
-
Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-?B Signaling. Int J Mol Sci. 2023 Mar 15; 24(6).
-
Panobinostat Induced Spatial In Situ Biomarkers Predictive of Anti-PD-1 Efficacy in Mouse Mammary Carcinoma. Cells. 2023 01 13; 12(2).
-
Galectin-3 is Associated with Heart Failure Incidence: A Meta-Analysis. Curr Cardiol Rev. 2023; 19(3):e171122211004.
-
Neurodegeneration Markers Galectin-3 and Apolipoprotein E Are Elevated in the Aqueous Humor of Eyes With Glaucoma. Transl Vis Sci Technol. 2022 11 01; 11(11):1.